Condensed Consolidated Statements of Stockholders Equity - USD ($) $ in Thousands |
Total |
Mantle Therapeutics Inc. [Member] |
2023 ESPP [Member] |
May 2025 Private Placement [Member] |
Leerink At The Market Sales Agreement [Member] |
Common Stock [Member] |
Common Stock [Member]
Mantle Therapeutics Inc. [Member]
|
Common Stock [Member]
2023 ESPP [Member]
|
Common Stock [Member]
May 2025 Private Placement [Member]
|
Common Stock [Member]
Leerink At The Market Sales Agreement [Member]
|
Treasury Stock [Member] |
Additional Paid-in Capital [Member] |
Additional Paid-in Capital [Member]
Mantle Therapeutics Inc. [Member]
|
Additional Paid-in Capital [Member]
2023 ESPP [Member]
|
Additional Paid-in Capital [Member]
May 2025 Private Placement [Member]
|
Additional Paid-in Capital [Member]
Leerink At The Market Sales Agreement [Member]
|
Accumulated Other Comprehensive Income (Loss) [Member] |
Accumulated Deficit [Member] |
| Balance, shares at Dec. 31, 2024 |
|
|
|
|
|
33,071,261
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Dec. 31, 2024 |
$ 116,842
|
|
|
|
|
$ 3
|
|
|
|
|
$ (17)
|
$ 397,132
|
|
|
|
|
$ (103)
|
$ (280,173)
|
| Issuance of common stock upon vesting and settlement of restricted stock units, shares |
|
|
|
|
|
52,446
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock, Shares |
|
|
|
|
|
|
|
65,342
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock, Value |
|
|
$ 170
|
|
|
|
|
|
|
|
|
|
|
$ 170
|
|
|
|
|
| Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Shares |
|
|
|
|
|
2,816
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Value |
13
|
|
|
|
|
|
|
|
|
|
|
13
|
|
|
|
|
|
|
| Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities |
49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
49
|
|
| Stock-based compensation expense |
3,697
|
|
|
|
|
|
|
|
|
|
|
3,697
|
|
|
|
|
|
|
| Net loss |
(32,656)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(32,656)
|
| Balance, shares at Mar. 31, 2025 |
|
|
|
|
|
33,191,865
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Mar. 31, 2025 |
88,115
|
|
|
|
|
$ 3
|
|
|
|
|
(17)
|
401,012
|
|
|
|
|
(54)
|
(312,829)
|
| Balance, shares at Dec. 31, 2024 |
|
|
|
|
|
33,071,261
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Dec. 31, 2024 |
116,842
|
|
|
|
|
$ 3
|
|
|
|
|
(17)
|
397,132
|
|
|
|
|
(103)
|
(280,173)
|
| Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities |
192
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
(79,042)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, shares at Sep. 30, 2025 |
|
|
|
|
|
54,934,275
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Sep. 30, 2025 |
120,831
|
|
|
|
|
$ 5
|
|
|
|
|
(17)
|
479,969
|
|
|
|
|
89
|
(359,215)
|
| Balance, shares at Dec. 31, 2024 |
|
|
|
|
|
33,071,261
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Dec. 31, 2024 |
116,842
|
|
|
|
|
$ 3
|
|
|
|
|
(17)
|
397,132
|
|
|
|
|
(103)
|
(280,173)
|
| Net loss |
(100,000)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, shares at Dec. 31, 2025 |
|
|
|
|
|
73,001,350
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Dec. 31, 2025 |
246,669
|
|
|
|
|
$ 7
|
|
|
|
|
(17)
|
626,625
|
|
|
|
|
188
|
(380,134)
|
| Balance, shares at Mar. 31, 2025 |
|
|
|
|
|
33,191,865
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Mar. 31, 2025 |
88,115
|
|
|
|
|
$ 3
|
|
|
|
|
(17)
|
401,012
|
|
|
|
|
(54)
|
(312,829)
|
| Issuance of common stock upon vesting and settlement of restricted stock units, shares |
|
|
|
|
|
14,097
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock, Shares |
|
|
|
|
|
|
|
|
20,790,120
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock, Value |
|
|
|
$ 73,082
|
|
|
|
|
$ 2
|
|
|
|
|
|
$ 73,080
|
|
|
|
| Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Shares |
|
|
|
|
|
2,410
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Value |
12
|
|
|
|
|
|
|
|
|
|
|
12
|
|
|
|
|
|
|
| Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities |
41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41
|
|
| Stock-based compensation expense |
3,071
|
|
|
|
|
|
|
|
|
|
|
3,071
|
|
|
|
|
|
|
| Net loss |
(26,103)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(26,103)
|
| Balance, shares at Jun. 30, 2025 |
|
|
|
|
|
53,998,492
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Jun. 30, 2025 |
138,218
|
|
|
|
|
$ 5
|
|
|
|
|
(17)
|
477,175
|
|
|
|
|
(13)
|
(338,932)
|
| Issuance of common stock upon vesting and settlement of restricted stock units, shares |
|
|
|
|
|
20,466
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock, Shares |
|
|
|
|
|
|
|
37,495
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock, Value |
|
|
101
|
|
|
|
|
|
|
|
|
|
|
101
|
|
|
|
|
| Exercise of stock options, shares |
|
|
|
|
|
9,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise of stock options, value |
34
|
|
|
|
|
|
|
|
|
|
|
34
|
|
|
|
|
|
|
| Issuance of common stock upon exercise of pre-funded warrants, shares |
|
|
|
|
|
867,302
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Shares |
|
|
|
|
|
1,520
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Value |
8
|
|
|
|
|
|
|
|
|
|
|
8
|
|
|
|
|
|
|
| Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities |
102
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
102
|
|
| Stock-based compensation expense |
2,651
|
|
|
|
|
|
|
|
|
|
|
2,651
|
|
|
|
|
|
|
| Net loss |
(20,283)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(20,283)
|
| Balance, shares at Sep. 30, 2025 |
|
|
|
|
|
54,934,275
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Sep. 30, 2025 |
120,831
|
|
|
|
|
$ 5
|
|
|
|
|
(17)
|
479,969
|
|
|
|
|
89
|
(359,215)
|
| Balance, shares at Dec. 31, 2025 |
|
|
|
|
|
73,001,350
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Dec. 31, 2025 |
246,669
|
|
|
|
|
$ 7
|
|
|
|
|
(17)
|
626,625
|
|
|
|
|
188
|
(380,134)
|
| Issuance of common stock upon vesting and settlement of restricted stock units, shares |
|
|
|
|
|
163,310
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock, Shares |
|
|
|
|
|
867,302
|
|
52,285
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock, Value |
2,446
|
|
143
|
|
|
|
|
|
|
|
|
2,446
|
|
143
|
|
|
|
|
| Exercise of stock options, shares |
|
|
|
|
|
2,400
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise of stock options, value |
9
|
|
|
|
|
|
|
|
|
|
|
9
|
|
|
|
|
|
|
| Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Shares |
|
|
|
|
|
90
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Value |
1
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
| Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities |
(330)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(330)
|
|
| Stock-based compensation expense |
2,755
|
|
|
|
|
|
|
|
|
|
|
2,755
|
|
|
|
|
|
|
| Net loss |
(20,196)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(20,196)
|
| Balance, shares at Mar. 31, 2026 |
|
|
|
|
|
74,086,737
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Mar. 31, 2026 |
231,497
|
|
|
|
|
$ 7
|
|
|
|
|
(17)
|
631,979
|
|
|
|
|
(142)
|
(400,330)
|
| Balance, shares at Dec. 31, 2025 |
|
|
|
|
|
73,001,350
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Dec. 31, 2025 |
246,669
|
|
|
|
|
$ 7
|
|
|
|
|
(17)
|
626,625
|
|
|
|
|
188
|
(380,134)
|
| Issuance of common stock, Shares |
|
|
|
|
|
|
|
|
|
7,533,881
|
|
|
|
|
|
|
|
|
| Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities |
(653)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
(84,363)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, shares at Sep. 30, 2026 |
|
|
|
|
|
82,785,830
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Sep. 30, 2026 |
216,691
|
|
|
|
|
$ 8
|
|
|
|
|
(17)
|
681,662
|
|
|
|
|
(465)
|
(464,497)
|
| Balance, shares at Mar. 31, 2026 |
|
|
|
|
|
74,086,737
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Mar. 31, 2026 |
231,497
|
|
|
|
|
$ 7
|
|
|
|
|
(17)
|
631,979
|
|
|
|
|
(142)
|
(400,330)
|
| Issuance of common stock upon vesting and settlement of restricted stock units, shares |
|
|
|
|
|
47,211
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock, Shares |
|
|
|
|
|
|
|
|
|
4,424,778
|
|
|
|
|
|
|
|
|
| Issuance of common stock, Value |
|
|
|
|
$ 23,576
|
|
|
|
|
$ 1
|
|
|
|
|
|
$ 23,575
|
|
|
| Exercise of stock options, shares |
|
|
|
|
|
63,818
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise of stock options, value |
320
|
|
|
|
|
|
|
|
|
|
|
320
|
|
|
|
|
|
|
| Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Shares |
|
|
|
|
|
60
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Value |
1
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
| Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities |
(156)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(156)
|
|
| Stock-based compensation expense |
5,690
|
|
|
|
|
|
|
|
|
|
|
5,690
|
|
|
|
|
|
|
| Net loss |
(25,867)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(25,867)
|
| Balance, shares at Jun. 30, 2026 |
|
|
|
|
|
78,622,604
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Jun. 30, 2026 |
235,061
|
|
|
|
|
$ 8
|
|
|
|
|
(17)
|
661,565
|
|
|
|
|
(298)
|
(426,197)
|
| Issuance of common stock upon vesting and settlement of restricted stock units and performance restricted stock units, shares |
|
|
|
|
|
362,008
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock, Shares |
|
|
|
|
|
|
|
59,148
|
|
3,109,103
|
|
|
|
|
|
|
|
|
| Issuance of common stock, Value |
|
|
$ 163
|
|
$ 14,077
|
|
|
|
|
|
|
|
|
$ 163
|
|
$ 14,077
|
|
|
| Issuance of common stock aquisition, Shares |
|
|
|
|
|
|
632,907
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of common stock acquisition |
|
$ 2,165
|
|
|
|
|
|
|
|
|
|
|
$ 2,165
|
|
|
|
|
|
| Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, Shares |
|
|
|
|
|
60
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unrealized comprehensive gain (loss) on investments in U.S. Treasury securities |
(167)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(167)
|
|
| Stock-based compensation expense |
3,692
|
|
|
|
|
|
|
|
|
|
|
3,692
|
|
|
|
|
|
|
| Net loss |
(38,300)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(38,300)
|
| Balance, shares at Sep. 30, 2026 |
|
|
|
|
|
82,785,830
|
|
|
|
|
|
|
|
|
|
|
|
|
| Balance, value at Sep. 30, 2026 |
$ 216,691
|
|
|
|
|
$ 8
|
|
|
|
|
$ (17)
|
$ 681,662
|
|
|
|
|
$ (465)
|
$ (464,497)
|